Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia

Leukemia

Volumn 10, Issue 3, 1996, Pages 494-497

  Rossi, E ^a,b   Matutes, E ^a   Morilla, R ^a   Owusu Ankomah, K ^a   Heffernan, A M ^a   Catovsky, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

CD28; CLL; T lymphocytes; Zeta chain

Indexed keywords

ALEMTUZUMAB; ALKYLATING AGENT; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FLUDARABINE; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR;

ARTICLE; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029942655     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Catovsky D, Lauria F, Matutes E et al. Increase in T lymphocytes in B-cell chronic lymphocytic leukaemia: correlation with clinical stage and findings in B-prolymphocytic leukaemia. Br J Haematol 1981; 47: 539-544.
2. Totterman TH, Carlsson M, Simonsson B, Bengtsson M, Nilsson K. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. Blood 1989; 74: 786-792.
3. Peller S, Kaufman S. Decreased CD45RA T cells in B-cell chronic lymphocytic leukemia patients: correlation with disease stage. Blood 1991; 78: 1569-1573.
4. Prieto A, Garcia Suarez J, Reyes E, Lapena P, Hernandez M, Alvarez Mon M. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Exp Hematol 1993; 21: 1563-1569.
5. Wolos JA, Davey FR. Function of lymphocyte subpopulations in chronic lymphocytic leukemia: activity in the allogeneic and autologous mixed lymphocyte reaction. Cancer 1980; 45: 893-898.
6. Foa R, Fierro MT, Raspadori D et al. Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors. Blood 1990; 76: 1349-1354.
7. Dianzani P, Omedé P, Marmont F et al. Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype. Blood 1994; 83: 2198-2205.
8. Rudd CE, Janssen O, Cai Y-C, da Silva AJ, Raab M, Prasad KVS. Two-step TCRz/CD3-CD4 and CD28 signalling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today 1994; 15: 225-234.
9. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994; 76: 263-274.
10. Anderson P, Blue M-L, O'Brien C, Schlossman SF. Monoclonal antibodies reactive with the T cell receptor z chain: production and characterisation using a new method. J Immunol 1989; 143: 1899-1904.
11. Anderson P, Cagliuri M, O'Brien C, Manley T, Ritz J, Schlossman SF. Fcg receptor type III (CD16) is included in the z NK receptor complex expressed by human natural killer cells Proc Natl Acad Sci USA 1990; 87: 2274-2278
12. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258: 1795-1798.
13. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen Annu Rev Immunol 1993; 11: 191-212.
14. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645.
15. Binet JL, Auquier A, Dighiero G et al. A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer 1981; 48: 198-206.
16. Farahat N, van der Plas D, Praxedes M, Morilla R, Matutes E, Catovsky D. Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry. J Clin Pathol 1994; 47: 843-849
17. + mature T lymphocytes. J Immunol 1990; 144: 1646-1653.
18. Massaia M, Attisano C, Beggiato E, Bianchi A, Pileri A. Correlation between disease activity and T cell CD3z chain expression in a B cell lymphoma. Br J Haematol 1994; 88: 886-888.
19. Nakagomi H, Petersson M, Magnusson I et al. Decreased expression of the signal-transducing z chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 1993; 53: 5610-5612.
20. Finke JH, Zea AH, Stanley J et al. Loss of T-cell receptor z chain and p56-lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 1993; 53: 5613-5616.
21. Oliver RT, Nouri AM. T-cell immunoresponse to cancer in humans and its relevance for immunodiagnosis and therapy. Cancer Surv 1992; 13: 173-204.
22. Letourneur F, Klausner R. Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 e. Science 1992; 255: 79-82.
23. Romeo C, Seed B. Cellular immunity to HIV activated by CD4 fused to T cell receptor of Fc receptor polypeptides. Cell 1991; 64. 1037-1046.
24. Irving BA, Weiss A. The cytoplasmic domain of the T cell receptor z chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 1991; 64: 891-901.
25. Hwu P, Shafer GE, Treisman J et al. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor g chain. J Exp Med 1993; 178: 361-366.
26. Koyasu S, D'Adamio L, Arulanandam ARN, Abraham S, Clayton LK, Reinherz EL. T cell receptor complex containing FceRIg homodimers in lieu of CD3z and CD3h components: a novel isoform expressed on large granular lymphocytes. J Exp Med 1992; 175: 203-209.
27. Iwashima M, Irving BA, van Oers NSC, Chan A, Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 1994; 263: 1136-1139.
28. + T cells from HIV-infected persons. J Immunol 1994; 153: 412-420.
29. - T cells. AIDS 1994; 8: 431-441.
30. Guinan EC, Gribben IG, Boussiotis VA, Freeman GJ, Nadler LM. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994; 84: 3261-3282.
31. - cells. J Exp Med 1994; 179: 1957-1972.
32. Testi R, Lanier LL. Functional expression of CD28 on T-cell antigen receptor gamma/delta-bearing T lymphocytes. Eur J Immunol 1986; 19: 185-188.